AVLIX
Price
$8.57
Change
+$0.07 (+0.82%)
Updated
Oct 20 closing price
Net Assets
2.17B
VVIAX
Price
$72.97
Change
+$0.55 (+0.76%)
Updated
Oct 20 closing price
Net Assets
207.8B
Interact to see
Advertisement

AVLIX vs VVIAX

Header iconAVLIX vs VVIAX Comparison
Open Charts AVLIX vs VVIAXBanner chart's image
American Century Value I
Price$8.57
Change+$0.07 (+0.82%)
VolumeN/A
Net Assets2.17B
Vanguard Value Index Adm
Price$72.97
Change+$0.55 (+0.76%)
VolumeN/A
Net Assets207.8B
AVLIX vs VVIAX Comparison Chart in %
View a ticker or compare two or three
VS
AVLIX vs. VVIAX commentary
Oct 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVLIX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 208B vs. AVLIX (2.17B). VVIAX pays higher dividends than AVLIX: VVIAX (2.08) vs AVLIX (1.77). AVLIX was incepted earlier than VVIAX: AVLIX (28 years) vs VVIAX (25 years). AVLIX (0.78) is less costly to investors than VVIAX (0.05). AVLIX is a more actively managed with annual turnover of: 44.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than AVLIX: VVIAX (3000) vs AVLIX (5000000). VVIAX annual gain was more profitable for investors over the last year : 4.55 vs. AVLIX (-0.81). VVIAX return over 5 years is better than : 74.40 vs. AVLIX (31.71).
AVLIXVVIAXAVLIX / VVIAX
Total Expense Ratio0.750.051,500%
Annual Report Gross Expense Ratio0.780.051,560%
Fund Existence28 years25 years-
Gain YTD11.5649.746119%
Front LoadN/AN/A-
Min. Initial Investment50000003000166,667%
Min. Initial Investment IRAN/AN/A-
Net Assets2.17B208B1%
Annual Yield % from dividends1.772.0885%
Returns for 1 year-0.814.55-18%
Returns for 3 years10.4241.7225%
Returns for 5 years31.7174.4043%
Returns for 10 years22.96124.6018%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HEMZX8.10N/A
N/A
Virtus SGA Emerging Markets Equity A
JSEAX22.59N/A
N/A
JPMorgan International Equity A
PHSYX67.29N/A
N/A
Putnam Global Health Care Y
BMISX7.47N/A
N/A
BNY Mellon Income Stock C
UIVIX13.02N/A
N/A
MFS Intrinsic Value I